Marksans Pharma’s UK arm gets MHRA nod for pain-relief tablets

Marksans Pharma’s UK subsidiary Relonchem has received MHRA authorisation to market 250 mg and 500 mg Mefenamic Acid tablets.

Leave a Reply

Your email address will not be published. Required fields are marked *